Application
Western blot analysis of GBP6 Antibody (C-term)（) in MCF-7 cell line lysates (35ug/lane). GBP6 (arrow) was detected using the purified Pab.Application
GBP6 Antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GBP6 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | GBP6 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | GBP6 Guanylate-binding protein 6 GTP-binding protein 6 Guanine nucleotide-binding protein 6 |
|---|---|
| Molecular Weight(MW) | 72427 Da |
| Function | Binds GTP, GDP and GMP (By similarity). |
| Tissue Specificity | This GBP6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 482~511 amino acids from the C-terminal region of human GBP6. |
| Entrez Gene | 163351 |
|---|
Application
Western blot analysis of GBP6 Antibody (C-term)（) in MCF-7 cell line lysates (35ug/lane). GBP6 (arrow) was detected using the purified Pab.
Application
GBP6 Antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the GBP6 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
